| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Thursday, November 29, 2018 At last, after back-and-forth speculation and denials, Bayer has revealed it will indeed cast off its animal health unit, a few consumer health brands and 12,000 jobs amid a large-scale restructuring that touches every area of its business. |
|
|
| This week's sponsor is FierceBiotech. | |  | |
Top Stories Of The Week Tuesday, November 27, 2018 Abeona Therapeutics CEO Carsten Thiel has been sacked after an investigation into “allegations of misconduct towards colleagues” and will be replaced immediately by head of R&D João Siffert. Wednesday, November 28, 2018 Pfizer, looking to protect billions in Lyrica sales, has been gunning for a 6-month pediatric exclusivity extension for its top drug. And on Tuesday, the FDA came through in favor of the drugmaker. Tuesday, November 27, 2018 Janssen Research & Development’s global head of discovery, Dashyant Dhanak, Ph.D., is joining Incyte to serve as its chief scientific officer, effective Dec. 10. He will take over for Reid Huber, Ph.D., who has moved on to become a partner at Third Rock Ventures. Wednesday, November 28, 2018 When a suspected carcinogen was detected by a U.S. drugmaker last summer in the API it had acquired to make blood pressure drugs, it first appeared to be another issue of tainted products produced in China. Since then, the FDA has learned the problem is much broader, with two of the largest generics drugmakers now recalling dozens of lots after Mylan found a suspected carcinogen in the API it produced. Thursday, November 22, 2018 The gut microbiome is widely viewed as a potential target for novel therapeutics, and not just for gastrointestinal conditions. Now an award-winning study finds that a disruption of the biological clock and obesity's "signature" on the gut microbiome could explain obesity. Wednesday, November 28, 2018 Novo Nordisk’s oral semaglutide is heading toward a market shake-up. And the company wants to see that happen sooner rather than later. The Danish drugmaker is considering using a priority review voucher for the candidate. Monday, November 26, 2018 A yearlong global investigation into the safety of medical devices analyzed 10 years of FDA data and found more than 1.7 million injuries and 83,000 deaths linked to approved and cleared devices, while the agency moves to modernize its 510(k) clearance pathway. Wednesday, November 28, 2018 It isn’t a scene one would expect after a severe flu season put vaccine makers on notice. But in China, the supply of flu vaccines this season has shrunk, thanks to reduced offerings from Sanofi Pasteur, a high-profile vaccine scandal and a nasty fight for control over a Nasdaq-listed company. Tuesday, November 20, 2018 Belgium biopharma UCB has partnered with Verint Systems to launch a new app for Parkinson’s patients that offers support and adherence. Resources Sponsored by: Almac Diagnostic Services, part of the Almac Group Download the whitepaper to learn more. Sponsored by: Reprints Desk, Inc. Learn how to fast-track your research workflows! Sponsored by: Veeva Industry Research: Read the 2018 Unified Clinical Operations Report to find out how pharmas and CROs are evolving clinical trial processes. Sponsored by: Applied BioMath This on-demand webinar introduces a quantitative systems pharmacology (QSP) model of targeted anabolic growth factors for intra-articular injection for the treatment of diseased joints. Sponsored by: Oracle Health Sciences New research reveals more than 50% of clinical data management professionals surveyed, are not confident in the quality and completeness of their clinical trial data. Sponsored by: Veradigm New Case Study – Leveraging Real-World Evidence From EHR to Assess Migraine Management Sponsored by: Signals Analytics What does data tell us about the future of cell & gene therapy? Sponsored by: Patheon, part of Thermo Fisher Scientific Download the whitepaper to learn more. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. | 
